Fibryna® (fibrinogen [human]) – New drug approval
June 7, 2017 – The FDA approved Octapharma’s Fibryna (fibrinogen [human]), for the treatment of acute bleeding episodes in adults and adolescents with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia.
Download PDF
